Farming It Out

Premium

If you want to start a major argument among industrial drug discovery chemists, start talking about outsourcing. "It's working out great," some of them will say. "We can farm out all the boring methyl-ethyl- butyl-futile compounds, and just work on the interesting stuff here." "Well, that's just great for those of you who still have jobs," comes one answer, "but what about those of us who've been laid off during all those mergers?" And someone else may well join in by saying "And you know, not all that outsourced chemistry works out the way it's supposed to.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.